Open AccessCost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections
Author(s) -
David Hutton,
Mehlika Toy,
Joshua A. Salomon,
Erin E. Conners,
Noele P. Nelson,
Aaron M. Harris,
Samuel So
Publication year - 2022
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001632
Subject(s) - medicine , vaccination , hbsag , hepatitis b , hepatitis b virus , population , hepatitis b vaccine , cost effectiveness , transmission (telecommunications) , health care , medicaid , family medicine , immunology , environmental health , virus , risk analysis (engineering) , economic growth , economics , electrical engineering , engineering
The estimated number of people living with hepatitis B virus (HBV) infection acquired through sexual transmission was 103,000 in 2018, with an estimated incidence of 8300 new cases per year. Although hepatitis B (HepB) vaccination is recommended by the Advisory Committee for Immunization Practices for persons seeking evaluation and treatment for sexually transmitted infections (STIs), prevaccination testing is not yet recommended. Screening may link persons with chronic hepatitis B to care and reduce unnecessary vaccination.